Active Ingredient: SITAGLIPTIN HYDROCHLORIDE
Proprietary Name: BRYNOVIN
Dosage Form; Route of Administration: SOLUTION; ORAL
Strength: EQ 25MG BASE/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N219122
Product Number: 001
Approval Date: Jan 16, 2025
Applicant Holder Full Name: AZURITY PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
